[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100610560":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":62,"collaborators":10,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":72,"eligibilityCriteria":73,"healthyVolunteers":68,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":10,"studyType":80,"phases":10,"briefSummary":81,"conditions":82,"keywords":87,"overallStatus":21,"whyStopped":10,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"San Raffaele Telematic University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"GLP-1 Agonist Treated Patients",null,"This cohort includes adult patients aged 18-60 who have been treated with GLP-1 receptor agonists such as semaglutide or tirzepatide for weight loss in specialized nutrition centers in Italy. The study collects retrospective data on changes in taste perception, eating habits, body composition, and treatment adherence over a minimum duration of 12 weeks of therapy. No interventional treatments are administered as part of this observational study.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Mauro Lombardo, MD","CONTACT","+393899740197","mauro.lombardo@uniroma5.it",[19,37,50,55],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":23,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"San Raffaele Open University","RECRUITING","Roma","Italy","00166","IT",{"type":27,"coordinates":28},"Point",[29,30],11.10642,44.99364,{"lat":30,"lon":29},[33],{"name":34,"role":15,"phone":35,"phoneExt":10,"email":36},"Stefania Supino, PhD","+39 800 128 606","stefania.supino@uniroma5.it",{"facility":38,"status":21,"city":39,"state":10,"zip":24,"country":23,"countryCode":25,"cosmosGeoPoint":40,"geoPoint":44,"contacts":45},"Department for the Promotion of Human Science and Quality of Life San Raffaele Open University","Rome",{"type":27,"coordinates":41},[42,43],12.51133,41.89193,{"lat":43,"lon":42},[46],{"name":47,"role":15,"phone":48,"phoneExt":10,"email":49},"Alessandra Feraco, PhD","+39 339 869 8874","alessandra.feraco@uniorma5.it",{"facility":20,"status":51,"city":39,"state":10,"zip":24,"country":23,"countryCode":25,"cosmosGeoPoint":52,"geoPoint":54,"contacts":10},"ACTIVE_NOT_RECRUITING",{"type":27,"coordinates":53},[42,43],{"lat":43,"lon":42},{"facility":20,"status":21,"city":39,"state":10,"zip":24,"country":23,"countryCode":25,"cosmosGeoPoint":56,"geoPoint":58,"contacts":59},{"type":27,"coordinates":57},[42,43],{"lat":43,"lon":42},[60],{"name":61,"role":15,"phone":16,"phoneExt":10,"email":10},"Mauro Lombado",{"type":63,"investigatorFullName":64,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Mauro Lombardo","Full professor in Human Nutrition","100610560","changes-in-taste-and-eating-habits-associated-with-glp-1-agonists-in-weight-loss-patients-100610560",false,"NCT07229170","Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients","Changes in Taste Perception, Eating Habits, and Other Behavioral Aspects Associated With the Use of GLP-1 Receptor Agonists in Patients Undergoing Weight Loss Treatment: A Retrospective Observational Study.","GLP1-TASTE","Inclusion: Adults aged 18-60 years diagnosed with obesity and undergoing treatment with GLP-1 receptor agonists such as semaglutide or tirzepatide. Must have clinical records and dietary data available for at least 12 weeks of treatment.\n\nExclusion: Patients with conditions affecting taste independent of GLP-1 treatment, severe comorbidities, or inability to provide consent and data.","ALL","18 Years","60 Years",{"count":78,"type":79},150,"ESTIMATED","OBSERVATIONAL","This observational retrospective study aims to evaluate changes in taste perception, eating habits, and behavioral aspects in adults treated with GLP-1 receptor agonists for weight loss. Participants include adults aged 18-60 receiving treatment at specialized nutrition centers in Italy. Data are collected from clinical records, dietary questionnaires, and metabolic assessments before and after at least 12 weeks of GLP-1 agonist treatment. The study's primary goal is to understand how these treatments affect food preferences and taste perception. Secondary outcomes include changes in body weight, body composition, gastrointestinal side effects, and treatment adherence. All data are anonymized and collected according to ethical guidelines.",[83,84,85,86],"Obesity & Overweight","Taste Alterations","Weight Loss","Eating Behavior Changes",[88,89,90,91,92,93],"GLP-1 agonists","Obesity treatment","Weight loss","Taste perception","Eating habits","Observational study","2026-04-22",{"date":96,"type":97},"2026-04-28","ACTUAL",{"date":99,"type":97},"2025-12-01",{"date":101,"type":79},"2028-01-01",{"name":5,"class":6},4]